ADVERTISEMENT
Sponsored
Videos
Alexey Danilov, MD, PhD, Discusses the Use of Acalabrutinib for the Treatment of CLL, SLL, and MCL
01/02/2021
In this video, Dr Danilov, Oregon Health & Science University, Portland, Oregon, discusses the use of acalabrutinib (Calquence; AstraZeneca) as a treatment option for patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL).
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Visit the OLN Excellence Forums
Advertisement
Advertisement
Advertisement